Michael Kahn

Author PubWeight™ 69.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 2008 4.43
2 A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A 2004 3.95
3 Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res 2010 2.67
4 Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci U S A 2010 2.66
5 Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene 2005 2.41
6 Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci U S A 2007 2.15
7 Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation. Proc Natl Acad Sci U S A 2005 1.67
8 Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 2011 1.62
9 Data quality assessment for comparative effectiveness research in distributed data networks. Med Care 2013 1.56
10 Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J Biol Chem 2012 1.47
11 Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling. J Biol Chem 2010 1.41
12 Investigating Wnt signaling: a chemogenomic safari. Drug Discov Today 2005 1.37
13 Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res 2009 1.36
14 The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators. Adv Drug Deliv Rev 2010 1.36
15 Wnt/β-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming. Stem Cell Rev 2011 1.33
16 Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol 2012 1.30
17 Common cancer stem cell gene variants predict colon cancer recurrence. Clin Cancer Res 2011 1.30
18 Neutrophil transmigration triggers repair of the lung epithelium via beta-catenin signaling. Proc Natl Acad Sci U S A 2011 1.25
19 Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood 2011 1.24
20 Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2. Breast Cancer Res 2011 1.22
21 ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription. Med Chem 2005 1.18
22 Temporal knowledge representation for scheduling tasks in clinical trial protocols. Proc AMIA Symp 2002 1.17
23 Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol 2002 1.16
24 Wnt/catenin signaling in adult stem cell physiology and disease. Stem Cell Rev 2014 1.15
25 Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. PLoS One 2012 1.08
26 β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression. Cancer Res 2013 1.08
27 A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J Immunol 2002 1.08
28 NF-kappaB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injury. Br J Pharmacol 2005 1.02
29 A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression. Mol Cancer Res 2011 1.02
30 Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours. EMBO J 2013 1.02
31 The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cells. Curr Cancer Drug Targets 2011 1.01
32 Safely targeting cancer stem cells via selective catenin coactivator antagonism. Cancer Sci 2014 1.00
33 Role of β-catenin-regulated CCN matricellular proteins in epithelial repair after inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2013 0.99
34 Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc Natl Acad Sci U S A 2003 0.99
35 Hemodynamic activation of beta-catenin and T-cell-specific transcription factor signaling in vascular endothelium regulates fibronectin expression. Arterioscler Thromb Vasc Biol 2011 0.99
36 Recapitulation of the embryonic cardiovascular progenitor cell niche. Biomaterials 2011 0.95
37 Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. PLoS One 2012 0.95
38 Stem cells in colon cancer. Clin Colorectal Cancer 2008 0.94
39 Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells. PLoS One 2012 0.94
40 Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway. Int J Cancer 2013 0.93
41 Design, synthesis, and application of peptide secondary structure mimetics. Mini Rev Med Chem 2002 0.91
42 The potential of targeting Wnt/β-catenin in colon cancer. Expert Opin Ther Targets 2014 0.90
43 γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown. Neoplasia 2013 0.88
44 Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion. Stem Cells Transl Med 2011 0.87
45 Small molecules and stem cells. Potency and lineage commitment: the new quest for the fountain of youth. J Med Chem 2010 0.86
46 The small molecule Wnt signaling modulator ICG-001 improves contractile function in chronically infarcted rat myocardium. PLoS One 2013 0.86
47 Design, synthesis, and evaluation of opioid analogues with non-peptidic beta-turn scaffold: enkephalin and endomorphin mimetics. J Med Chem 2002 0.86
48 The airway epithelium in asthma: developmental issues that scar the airways for life? Pulm Pharmacol Ther 2012 0.84
49 Association of β-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-β1. J Cell Sci 2012 0.84
50 Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors. Biochim Biophys Acta 2010 0.84
51 Survivin in the human hair follicle. J Invest Dermatol 2006 0.82
52 A comprehensive framework for data quality assessment in CER. AMIA Jt Summits Transl Sci Proc 2013 0.81
53 Design and synthesis of phosphotyrosine mimetics. Bioorg Med Chem Lett 2003 0.78
54 A clinico-pathologic correlation. Cherubism. J Mass Dent Soc 2007 0.77
55 Chemogenomics with peptide secondary structure mimetics. Comb Chem High Throughput Screen 2003 0.76
56 In the current issue of Current Molecular Pharmacology (CMP-7-1), we are publishing three articles and a special issue. Preface. Curr Mol Pharmacol 2014 0.75
57 Woman with severe facial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008 0.75
58 High-throughput nanoparticle catalysis: partial oxidation of propylene. Comb Chem High Throughput Screen 2007 0.75
59 Nonpresenting Dichorionic Twins and Placental Vascular Malperfusion. Obstet Gynecol 2017 0.75
60 A clinico-pathologic correlation. Oral melanocanthoma with concomitant epithelial mild-to-severe dysplasia. J Mass Dent Soc 2011 0.75
61 A Case Report: Establishing a Definitive Airway in a Trauma Patient With a King Laryngeal Tube In Situ in the Presence of a Closed Head Injury and Difficult Airway: "Between the Devil and the Deep Blue Sea". A A Case Rep 2017 0.75
62 High-throughput synthesis and optimization of thrombin inhibitors via urazole alpha-addition and Michael addition. Bioorg Med Chem Lett 2003 0.75
63 A clinico-pathologic correlation. Aggressive fibromatosis and peripheral ossifying fibroma. J Mass Dent Soc 2006 0.75